Palisade Bio (STU:7NS0) Ending Cash Position : €10.40 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Ending Cash Position?

Palisade Bio's Ending Cash Position for the quarter that ended in Mar. 2024 was €10.40 Mil.

Palisade Bio's quarterly Ending Cash Position declined from Sep. 2023 (€14.37 Mil) to Dec. 2023 (€11.42 Mil) and declined from Dec. 2023 (€11.42 Mil) to Mar. 2024 (€10.40 Mil).

Palisade Bio's annual Ending Cash Position increased from Dec. 2021 (€9.31 Mil) to Dec. 2022 (€11.71 Mil) but then declined from Dec. 2022 (€11.71 Mil) to Dec. 2023 (€11.42 Mil).

Palisade Bio Ending Cash Position Historical Data

The historical data trend for Palisade Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Ending Cash Position Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

0.61

9.31

11.71

11.42

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial											12.44	15.16	14.37	11.42	10.40

Palisade Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Palisade Bio's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11.379	+	0.045
	=	11.42

Palisade Bio's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11.462	+	-1.064
	=	10.40

Palisade Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Palisade Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio (STU:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PALI:USA 7NS:Germany

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines